224 related articles for article (PubMed ID: 6956774)
1. Response of uremic osteoid to vitamin D.
Memmos DE; Eastwood JB; Harris E; O'Grady A; de Wardener HE
Kidney Int Suppl; 1982 May; 11():S50-4. PubMed ID: 6956774
[TBL] [Abstract][Full Text] [Related]
2. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.
Reed JS; Meredith SC; Nemchausky BA; Rosenberg IH; Boyer JL
Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289
[TBL] [Abstract][Full Text] [Related]
3. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
Malluche HH; Goldstein DA; Massry SG
J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Vitamin-D deficiency in the osteomalacia of chronic renal failure.
Eastwood JB; Stamp TC; Harris E; de Wardener HE
Lancet; 1976 Dec; 2(7997):1209-11. PubMed ID: 63038
[TBL] [Abstract][Full Text] [Related]
7. Osteomalacia in chronic renal failure before dialysis.
Mora Palma FJ; Lorenzo Sellares V; Ellis HA; Ward MK; Kerr DN
Proc Eur Dial Transplant Assoc; 1983; 19():188-94. PubMed ID: 6878233
[TBL] [Abstract][Full Text] [Related]
8. Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.
Bordier P; Pechet MM; Hesse R; Marie P; Rasmussen H
N Engl J Med; 1974 Oct; 291(17):866-71. PubMed ID: 4415589
[No Abstract] [Full Text] [Related]
9. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure.
Eastwood JB; Stamp TC; De Wardener HE; Bordier PJ; Arnaud CD
Clin Sci Mol Med; 1977 May; 52(5):499-508. PubMed ID: 862343
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
11. The action of 1,25 (OH)2D3 on turnover kinetic, remodelling surfaces and structure of trabecular bone in chronic renal failure.
Delling G; Lühmann H; Bulla M; Fuchs C; Henning HV; Jansen JL; Kohnle W; Schulz W
Contrib Nephrol; 1980; 18():105-21. PubMed ID: 7353369
[TBL] [Abstract][Full Text] [Related]
12. [4 cases of osteomalacia during anticonvulsant or sedative treatment].
Alcalay M; Amor B; Bontoux D; Cayla J; Charbonnier A; Mery C; Rondier J; Miravet L
Sem Hop; 1975 Dec; 51(49):3019-27. PubMed ID: 174222
[TBL] [Abstract][Full Text] [Related]
13. The natural course of dialysis osteomalacia.
Llach F; Felsenfeld AJ; Coleman MD; Keveney JJ; Pederson JA; Medlock TR
Kidney Int Suppl; 1986 Feb; 18():S74-9. PubMed ID: 3458001
[No Abstract] [Full Text] [Related]
14. [Quantitative histological study of osteoclastic resorption in primary and secondary hyperparathyroidism].
Meunier P; Vignon G; Vauzelle JL; Zech P
Pathol Biol (Paris); 1969 Nov; 17(21):927-38. PubMed ID: 4907648
[No Abstract] [Full Text] [Related]
15. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
[No Abstract] [Full Text] [Related]
16. [Treatment of secondary hyperparathyroidism with vitamin D metabolites].
Stojimirović B; Pejanović S; Djukanović Lj
Srp Arh Celok Lek; 1994; 122(7-8):197-9. PubMed ID: 17974384
[TBL] [Abstract][Full Text] [Related]
17. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
[TBL] [Abstract][Full Text] [Related]
18. Plasma 1,25(OH2) vitamin D concentrations in nutritional osteomalacia.
Eastwood JB; de Wardener HE; Gray RW; Lemann JL
Lancet; 1979 Sep; 2(8140):465. PubMed ID: 89519
[No Abstract] [Full Text] [Related]
19. Symptomatic osteomalacia after jejunoileal bypass surgery in a patient with primary hyperparathyroidism. A study of the change in bone morphology and vitamin D metabolites before and during treatment.
Taylor HC; Teitelbaum SL; Lambert PW
Gastroenterology; 1983 Sep; 85(3):735-42. PubMed ID: 6603388
[TBL] [Abstract][Full Text] [Related]
20. [Recent aspects on regulation of calcium metabolism. I. Vitamin D].
Nielsen SP
Ugeskr Laeger; 1973 Nov; 135(46):2504-7. PubMed ID: 4361021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
